The Rosselkhoznadzor, with the participation of its subordinate institution "Federal Center for Animal Health" (FGBI "ARRIAH"), held talks with the representatives of one of the largest pharmaceutical manufacturers in Thailand. The online meeting was initiated by the Thai party.
During the video conference the Thai side expressed interest in importing the vaccine aimed at preventing and reducing the risks of a pandemic in both domestic and wild animals. As the representatives of the Thai side explained, these risks are much higher in the Asian region due to the specific character of way of living, the large tourist flow and the climate.
In addition, the availability and use of the vaccine will reduce the likelihood of coronavirus mutations as coronavirus infection is characterized by interspecies transmission of the virus. This way of coronavirus prevention will be a serious positive argument for tourists who plan their holidays in Thailand.
The representatives of the Federal Center for Animal Health said that they are ready to send an initial batch of 10,000 doses.
On its part, the Thai pharmaceutical manufacturer promised to make every effort to negotiate with the state competent authorities of the Kingdom on the possibility of rapid registration and authorization of the vaccine in order to supply it to Thailand for commercial purposes.
The FGBI "ARRIAH" will send an export package of documents to the Thai colleagues in the near future. In addition, technical consultations will be held regarding the delivery of the vaccine to the territory of a foreign state.
Following the negotiations, the Rosselkhoznadzor-subordinate Federal Center for Animal Health and the largest manufacturer of nanonutrient products for humans and animals of the Kingdom of Thailand signed a memorandum of understanding. The document provides assistance to the pharmaceutical company in matters of national registration and supply of vaccines for prevention of novel coronavirus infection in animals.
During the talks it was also noted that the world's first registered vaccine against COVID-19 for animals has already aroused interest in Argentina, South Korea, Japan, the European Union, etc. The FGBI "ARRIAH" currently supplies a wide variety of animal vaccines to 21 countries around the world.